Cargando…

Aspirin as a neoadjuvant agent during preoperative chemoradiation for rectal cancer

BACKGROUND: Recently, many studies have suggested a possible adjuvant role of aspirin in colorectal cancer, reporting a positive prognostic effect with its use in patients with established disease. The aim of this study was to investigate the anticancer effect of aspirin use during preoperative chem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Restivo, Angelo, Cocco, Ivana Maria Francesca, Casula, Giuseppe, Scintu, Francesco, Cabras, Francesco, Scartozzi, Mario, Zorcolo, Luigi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647877/ https://www.ncbi.nlm.nih.gov/pubmed/26372700 http://dx.doi.org/10.1038/bjc.2015.336

Ejemplares similares

Metformin-associated lactic acidosis and temporary ileostomy: a case report
por: Margiani, Carla, et al.
Publicado: (2014)

Elevated platelet count is a negative predictive and prognostic marker in locally advanced rectal cancer undergoing neoadjuvant chemoradiation: a retrospective multi-institutional study on 965 patients
por: Belluco, Claudio, et al.
Publicado: (2018)

Preoperative MRI accuracy after neoadjuvant chemoradiation for locally advanced rectal cancer
por: Popiţa, Anca-Raluca, et al.
Publicado: (2023)

Colorectal cancer promoter methylation alteration affects the expression of glutamate ionotropic receptor AMPA type subunit 4 alternative isoforms potentially relevant in colon tissue
por: Vega-Benedetti, Ana Florencia, et al.
Publicado: (2021)

Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: should we be more cautious?
por: Glynne-Jones, R, et al.
Publicado: (2006)

Clinical outcome of neoadjuvant chemoradiation in rectal cancer treatment
por: Suwanthanma, Weerapat, et al.
Publicado: (2021)

Thymosin ß(4) expression in colorectal polyps and adenomas
por: Nemolato, Sonia, et al.
Publicado: (2013)

Neoadjuvant chemoradiation therapy and pathological complete response in rectal cancer
por: Ferrari, Linda, et al.
Publicado: (2015)

Magnetic-Resonance-Imaging Texture Analysis Predicts Early Progression in Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiation
por: Nardone, Valerio, et al.
Publicado: (2019)

Preoperative Chemoradiation in Locally Advanced Rectal Cancer: Efficacy and Safety
por: Peponi, Evangelia, et al.
Publicado: (2015)

Neoadjuvant chemoradiation for rectal cancer in patients aged 75 years or older
por: Lombardi, Raffaele, et al.
Publicado: (2009)

Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer
por: Dayde, Delphine, et al.
Publicado: (2017)

Colorectal Cancer Early Detection in Stool Samples Tracing CpG Islands Methylation Alterations Affecting Gene Expression
por: Vega-Benedetti, Ana Florencia, et al.
Publicado: (2020)

The Effects of Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer—The Impact in Intratumoral Heterogeneity
por: Bettoni, Fabiana, et al.
Publicado: (2019)

Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal Cancer
por: Ott, Oliver J., et al.
Publicado: (2021)

Identification of Blood-Based Biomarkers for the Prediction of the Response to Neoadjuvant Chemoradiation in Rectal Cancer
por: Dayde, Delphine, et al.
Publicado: (2021)

Optimized tools and timing of response reassessment after neoadjuvant chemoradiation in rectal cancer
por: Chen, Junbing, et al.
Publicado: (2022)

Treatment outcomes regarding the addition of targeted agents in the therapeutic portfolio for stage II-III rectal cancer undergoing neoadjuvant chemoradiation
por: Liang, Jin-Tung, et al.
Publicado: (2017)

Concurrent Aspirin Use Is Associated with Improved Outcome in Rectal Cancer Patients Who Undergo Chemoradiation Therapy
por: Farrugia, Mark K., et al.
Publicado: (2021)

Optimal timing of surgery after neoadjuvant chemoradiation therapy in locally advanced rectal cancer
por: Jeong, Duck Hyoun, et al.
Publicado: (2013)

Association of tumor differentiation and prognosis in patients with rectal cancer undergoing neoadjuvant chemoradiation therapy
por: Huang, Qunsheng, et al.
Publicado: (2019)

Neoadjuvant chemoradiation alters biomarkers of anticancer immunotherapy responses in locally advanced rectal cancer
por: Seo, Incheol, et al.
Publicado: (2021)

Evaluation and Predictive Factors of Complete Response in Rectal Cancer after Neoadjuvant Chemoradiation Therapy
por: Kokaine, Linda, et al.
Publicado: (2021)

Comparing outcomes following total neoadjuvant therapy and following neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer
por: Zhu, Shaoyu, et al.
Publicado: (2019)

Impact of the distal resection margin on local recurrence after neoadjuvant chemoradiation and rectal excision for locally advanced rectal cancer
por: Song, Seung Ho, et al.
Publicado: (2021)

Implications for selecting local excision in locally advanced rectal cancer after preoperative chemoradiation
por: Wan, Juefeng, et al.
Publicado: (2015)

Prognostic Impact of Immunonutritional Status Changes During Preoperative Chemoradiation in Patients With Rectal Cancer
por: Lee, Yong Joon, et al.
Publicado: (2016)

Tumor regression in rectal cancer after intensified neoadjuvant chemoradiation: a morphometric and clinicopathological study
por: Prall, Friedrich, et al.
Publicado: (2015)

Obesity as an independent predictive factor for pathologic complete response after neoadjuvant chemoradiation in rectal cancer
por: Lee, Soo Young, et al.
Publicado: (2019)

The Impact of Chronic Kidney Disease in Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiation
por: Dudani, Shaan, et al.
Publicado: (2021)

Predicting outcomes for locally advanced rectal cancer treated with neoadjuvant chemoradiation with CT-based radiomics
por: Wang, Fuqiang, et al.
Publicado: (2022)

Time to surgery and pathologic complete response after neoadjuvant chemoradiation in rectal cancer: A population study on 2094 patients
por: Macchia, Gabriella, et al.
Publicado: (2017)

Adaptive Individualized high-dose preoperAtive (AIDA) chemoradiation in high-risk rectal cancer: a phase II trial
por: Guido, Alessandra, et al.
Publicado: (2022)

Prognostic Significance of Serum Carcinoembryonic Antigen Normalization on Survival in Rectal Cancer Treated with Preoperative Chemoradiation
por: Chung, Mi-Joo, et al.
Publicado: (2013)

Immunohistochemical Detection of p53 Expression in Patients with Preoperative Chemoradiation for Rectal Cancer: Association with Prognosis
por: Huh, Jung Wook, et al.
Publicado: (2015)

Preoperative chemoradiation for locally advanced rectal cancer: comparison of three radiation dose and fractionation schedules
por: Park, Shin-Hyung, et al.
Publicado: (2016)

Five-year outcomes of preoperative chemoradiation for rectal carcinoma in Saudi population: single-institutional experience
por: AlSaeed, Eyad Fawzi, et al.
Publicado: (2015)

MRI Radiomics for Prediction of Tumor Response and Downstaging in Rectal Cancer Patients after Preoperative Chemoradiation
por: Chen, Haihui, et al.
Publicado: (2020)

A universal cell‐free DNA approach for response prediction to preoperative chemoradiation in rectal cancer
por: Grinshpun, Albert, et al.
Publicado: (2022)

What does absence of lymph node in resected specimen mean after neoadjuvant chemoradiation for rectal cancer
por: Lee, Won-Suk, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_4l1vvu3srasssuq2r718a0ipjj